Development Level

Tbio 70 | 10,625
Tchem 33 | 1,890
Tclin 16 | 602
Tdark 6 | 7,003

IMPC Term

preweaning lethality, complete... 4 | 633
abnormal behavior 2 | 226
abnormal coat/hair pigmentatio... 2 | 54
abnormal sleep behavior 2 | 63
decreased body weight 2 | 174
decreased circulating triglyce... 2 | 83
decreased lean body mass 2 | 195
embryonic lethality prior to o... 2 | 148
embryonic lethality prior to t... 2 | 187
increased circulating glucose ... 2 | 16
abnormal behavioral response t... 1 | 52
abnormal coping response 1 | 12
abnormal embryo size 1 | 112
abnormal femur morphology 1 | 14
abnormal lens morphology 1 | 73
abnormal respiratory quotient 1 | 9
abnormal whole-body plethysmog... 1 | 4
decreased T cell number 1 | 31
decreased body temperature 1 | 2
decreased bone mineral content 1 | 157
decreased circulating LDL chol... 1 | 37
decreased circulating alanine ... 1 | 53
decreased circulating amylase ... 1 | 24
decreased circulating chloride... 1 | 32
decreased fasted circulating g... 1 | 49
decreased heart weight 1 | 44
decreased mean corpuscular hem... 1 | 34
decreased mean corpuscular vol... 1 | 50
enlarged heart 1 | 111
enlarged lymph nodes 1 | 27
hypoactivity 1 | 89
immune system phenotype 1 | 17
impaired glucose tolerance 1 | 52
increased CD4-positive, alpha ... 1 | 15
increased blood uric acid leve... 1 | 5
increased body length 1 | 20
increased body weight 1 | 42
increased cellular hemoglobin ... 1 | 2
increased circulating HDL chol... 1 | 63
increased circulating glycerol... 1 | 11
increased circulating magnesiu... 1 | 10
increased circulating potassiu... 1 | 31
increased fasted circulating g... 1 | 68
increased lean body mass 1 | 107
increased leukocyte cell numbe... 1 | 37
increased mean corpuscular vol... 1 | 91
increased prepulse inhibition 1 | 21
long tibia 1 | 13
macrophthalmia 1 | 2
preweaning lethality, incomple... 1 | 260

Disease

psoriasis 83 | 6,685
Cancer 80 | 2,346
ovarian cancer 65 | 8,484
osteosarcoma 57 | 7,933
glioblastoma 54 | 5,572
lung cancer 48 | 4,466
interstitial cystitis 47 | 2,299
medulloblastoma, large-cell 47 | 6,234
tuberculosis 45 | 1,557
diabetes mellitus 40 | 1,663
cutaneous lupus erythematosus 38 | 1,056
invasive ductal carcinoma 38 | 2,950
ulcerative colitis 38 | 2,087
lung adenocarcinoma 37 | 2,713
malignant mesothelioma 37 | 3,162
atypical teratoid / rhabdoid tumor 36 | 4,369
lung carcinoma 36 | 2,844
Breast cancer 35 | 3,094
intraductal papillary-mucinous adenoma (IPMA) 33 | 2,956
non-small cell lung cancer 33 | 2,798
Hypersensitivity reaction type II disease 32 | 235
Multiple Sclerosis 32 | 498
intraductal papillary-mucinous carcinoma (IPMC) 32 | 2,988
pilocytic astrocytoma 31 | 3,086
intraductal papillary-mucinous neoplasm (IPMN) 30 | 3,289
Kidney disease 29 | 396
cystic fibrosis 29 | 1,665
Asthma 28 | 349
pancreatic cancer 28 | 2,300
Inflammatory bowel disease 27 | 142
Rheumatoid Arthritis 26 | 1,160
Lung disease 25 | 132
adult high grade glioma 24 | 2,148
juvenile dermatomyositis 24 | 1,189
subependymal giant cell astrocytoma 24 | 2,287
Arthritis 23 | 248
Atherosclerosis 23 | 275
astrocytoma 23 | 1,493
pituitary cancer 23 | 1,972
posterior fossa group A ependymoma 23 | 1,511
Liver disease 22 | 219
oligodendroglioma 22 | 2,849
pediatric high grade glioma 22 | 2,712
Dermatitis 21 | 107
Human immunodeficiency virus infectious disease 21 | 92
primary Sjogren syndrome 21 | 789
sarcoidosis 21 | 358
breast carcinoma 20 | 1,614
Cerebrovascular disease 19 | 231
group 4 medulloblastoma 19 | 1,875
Diarrhea 18 | 155
Heart disease 18 | 279
Influenza 18 | 142
ductal carcinoma in situ 18 | 1,745
nasopharyngeal carcinoma 18 | 1,056
Alzheimer's disease 17 | 644
colon cancer 17 | 1,475
dermatomyositis 17 | 933
esophageal adenocarcinoma 17 | 737
mucosa-associated lymphoid tissue lymphoma 17 | 480
periodontitis 17 | 269
Carcinoma 16 | 2,147
Coronary artery disease 16 | 240
ependymoma 16 | 2,514
primary pancreatic ductal adenocarcinoma 16 | 1,271
Acquired immunodeficiency syndrome 15 | 164
Atopic dermatitis 15 | 944
Encephalitis 15 | 54
Hypertension 15 | 287
Mammary Neoplasms 15 | 410
primitive neuroectodermal tumor 15 | 3,031
Allergic hypersensitivity disease 14 | 123
Anemia 14 | 252
Hepatitis C 14 | 90
Multiple myeloma 14 | 1,327
Peripheral Neuropathy 14 | 303
Hepatitis B 13 | 103
Inflammation 13 | 109
Malaria 13 | 140
Pneumonia 13 | 133
pancreatic ductal adenocarcinoma liver metastasis 13 | 1,795
Dementia 12 | 129
Endometriosis 12 | 535
Eosinophilia 12 | 65
Obesity 12 | 616
Prostatic Neoplasms 12 | 471
Schizophrenia 12 | 501
Toxic encephalopathy 12 | 131
Vasculitis 12 | 64
Waldenstrons macroglobulinemia 12 | 765
acute quadriplegic myopathy 12 | 1,157
astrocytic glioma 12 | 2,241
gastric carcinoma 12 | 832
head and neck cancer and chronic obstructive pulmonary disease 12 | 237
medulloblastoma 12 | 1,524
non-small cell lung carcinoma 12 | 413
spina bifida 12 | 1,064
Down syndrome 11 | 548
Pick disease 11 | 1,893
Vascular disease 11 | 281

Tissue

Blood and immune system 124 | 17,995
Digestive Tract 124 | 18,473
Female tissues 124 | 18,647
Cardiovascular System 123 | 17,958
Nervous System 123 | 18,561
Respiratory system 123 | 17,484
Urinary Tract 123 | 18,444
Endocrine System 122 | 18,512
Liver and Pancreas 122 | 18,136
Male tissues 122 | 17,969
Skin and soft tissues 122 | 18,115

Target Family

Non-IDG 82 | 11,971
Enzyme 22 | 4,146
Transcription Factor 10 | 1,400
GPCR 6 | 406
Kinase 4 | 634
Nuclear Receptor 1 | 48

Grant Application

5P51RR000164-50 125 | 125
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Prolyl endopeptidase PREP Tchem Enzyme -2.51026 335.2 140
60S ribosomal protein L7a RPL7A Tbio Non-IDG -1.66015 45.9 60
Ribonuclease inhibitor RNH1 Tbio Enzyme -2.79304 640.5 234
Tumor necrosis factor receptor superfamily member 6 FAS Tbio Non-IDG -3.27492 2052.7 1794
NKG2-A/NKG2-B type II integral membrane protein KLRC1 Tbio Non-IDG -2.40441 255.8 351
Ubiquitin carboxyl-terminal hydrolase 7 USP7 Tchem Enzyme -2.17350 165.7 375
Alpha-synuclein SNCA Tchem Non-IDG -3.59982 3997.3 1484
Forkhead box protein P3 FOXP3 Tbio Transcription Factor -3.60057 5680.3 1162
C-X-C motif chemokine 9 CXCL9 Tbio Non-IDG -2.88793 860.6 317